Michael A. Lanphere serves as Executive at TransBiotec, Inc., where they oversee executive responsibilities. Since joining the company, Michael A. Lanphere has executed 2 insider transactions totaling $520.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 28, 2019 involved purchasing 5,206,430 shares valued at $520.6K.
Michael A. Lanphere currently holds 50,144,878 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael A. Lanphere has been a net buyer of IMLE stock. They have purchased $520.6K and sold $0 worth of shares.
Michael A. Lanphere's most recent insider trade was on Aug 28, 2019, when they purchased 5,206,430 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |